Startup Genzada to build new HQ, renovate manufacturing facility in Kansas

Startup drugmaker Genzada Pharmaceuticals said it will build new headquarters in Sterling, KS, and renovate an existing building to house a “small-scale” manufacturing facility and R&D facility.

The company said it expects to create as many as 25 to 30 new jobs in the south-central Kansas town. The expansion for the headquarters is expected to be 10,000-square feet and be completed sometime next year, KWCH12 reported.

"The new space will allow us to continue to expand on achieving our mission, which is to eliminate diseases that induce human suffering,” Jason West, Genzada’s EVP, told the television station.

Whitepaper

Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

The company plans to seek FDA approval next year for human testing of various pharmaceutical products for rare and hard-to-treat cancers and other medical conditions.

Genzada has conducted studies with a combination of three chemical compounds, including a pair from plant-based material, West said.

-here’s the KWCH12 story

Suggested Articles

Fujifilm has completed the first manufacturing facility in Japan to make drug-delivering liposomes to use for cancer fighting drugs it is developing.

Three Samsung execs face up to two years in jail for their roles in destroying data and documents at under-fire affiliate Samsung BioLogics.

The FDA has slapped a U.S. drug repackager, saying in a warning letter that its storage processes and equipment cleaning are not up to expectations.